Additionally, TET3 and AHR expression levels were lower in the tumor grade 1 subgroup compared to the tumor grade 2/3 subgroups and lower in the tumor grade 2 subgroup compared to the tumor grade 3 subgroup (P < 0.001, Fig. 2B and I). The gene discussed is AHR; the disease is neoplasm.